Valuable Funding for Biomaterials Company
8 April 2011 A company whose synthetic bone-graft implants demonstrate world-beating performance will complete regulatory…
read moreOrthogem Ltd is a biomaterials company who have developed a new generation of synthetic bone graft substitute. The platform technology called Tripore consists of granules of hydroxyapatite (material which makes up natural bone) containing pores in a range of three sizes, meaning it is uniquely fully resorbable i.e. replaced by natural bone. The product and production process are patent protected, extending worldwide, allowing the company to develop a range of product extensions for use in a variety of clinical scenarios.
Status current
Associated Fund Early Advantage Fund
Sector Medical / Biotechnology
Website www.orthogem.com/index.asp
8 April 2011 A company whose synthetic bone-graft implants demonstrate world-beating performance will complete regulatory…
read moreDuring the period, with the exception of Ixaris and Orthogem as mentioned above, the...
read moreUpdate your browser to view this website correctly.Update my browser now